HealthUnlocked RSS Feed
Updated: 8 hours 21 min ago
Not only is CLL heterogeneous in watch and wait, that's also the case after treatment. An analysis of over 2,000 patients from three German CLL Study Group clinical trials has identified that unfit patients developing lymphadenopathy (swelling nodes) have a significantly lower median overall survival (OS) than fit patients or patients that develop increasing absolute lymphocyte counts. The authors concluded that “the results suggest that progression by lymphadenopathy is associated with a...